Review
Accepted on 31 Dec 2025
Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Type at least 3 characters
9,296 articles
articles
Review
Accepted on 31 Dec 2025
Urgent Considerations Regarding Renal Immune-related Adverse Events for Oncologists
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 31 Dec 2025
Ginkgo biloba extract suppresses hepatocellular carcinoma progression by inhibiting the recruitment of myeloid-derived suppressor cells through reduced CXCL1 secretion via SRC downregulation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 31 Dec 2025
Prognostic Value of PD-L1 Expression on Tumor-Infiltrating Immune Cells (TIICs) and Neutrophil-to-Lymphocyte Ratio (NLR) in Patients with Biliary Tract Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 31 Dec 2025
B cell phenotypes and antibody signatures associate with interpatient variation in the lung adenocarcinoma tumor microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Mini Review
Accepted on 31 Dec 2025
Immune Activation and Microenvironmental Crosstalk in Hairy Cell Leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 30 Dec 2025
FBXO9 promotes anti-tumor immunity via degradation of PD-L1 in pancreatic cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 297 views
Original Research
Accepted on 30 Dec 2025
Immune-Related Adverse Events and Neutrophil-to-Lymphocyte Ratio as Prognostic Indicators in Gynecologic Cancer Patients Receiving Pembrolizumab: A Real-World Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 30 Dec 2025
Adjuvant radiotherapy for patients with clinical T3-4 oral and oropharyngeal cancer who achieved major pathologic response after neoadjuvant immunochemotherapy and surgery: a propensity score-matched retrospective study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 30 Dec 2025
Sialylation-immune-related lncRNA LINC01605 promotes tumor-infiltrating CD8+ T cell exhaustion and malignancy of clear cell renal cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Editorial
Accepted on 30 Dec 2025
Editorial: Precision Oncology in Checkpoint Immunotherapy, Leveraging Predictive Biomarkers for Personalized Treatment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 30 Dec 2025
A monocyte-derived blood transcriptomic signature reveals systemic immunosuppression in HCC and partial reversal following curative therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
- 149 views
Review
Accepted on 30 Dec 2025
Glutamine metabolism remodels tumor-associated macrophage: mechanistic explorations and new strategies in translational medicine
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 29 Dec 2025
M2 Macrophage Infiltration Drives Tumor Progression and Identifies a Multigene Prognostic Signature in Esophageal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Editorial
Accepted on 29 Dec 2025
Editorial: Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Editorial
Accepted on 29 Dec 2025
Strategies Aimed at Improving the Effectiveness of Immunotherapies in Pediatric Brain Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 29 Dec 2025
PILRA serves as a diagnostic and prognostic biomarker and modulates the tumor immune microenvironment and immunotherapy response in breast cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Case Report
Accepted on 29 Dec 2025
Immune Checkpoint Inhibitor-induced Fulminant Diabetic Ketoacidosis: A Case-based Review and Considerations for Immunotherapy Discontinuation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Systematic Review
Accepted on 29 Dec 2025
Global Research Landscape of Ferroptosis in Gastric Cancer: A Multidisciplinary Bibliometric Analysis Based on Multiple Databases (2017-2025)
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 29 Dec 2025
SLC12A7 Serves as a Prognostic and Immunotherapeutic Biomarker Identified by Multi-Omics Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 29 Dec 2025
Comprehensive analysis of IGFL1 in colorectal cancer and its promotion of tumour progression via inhibition of lipophagy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Mini Review
Accepted on 29 Dec 2025
Exo-Nanomaterials in Cancer Immunotherapy: Reprogramming the Tumor Immune Microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Case Report
Accepted on 29 Dec 2025
Exceptional Response to Chemo-immunotherapy in a Patient with HER2-Negative, TMB-High Metastatic Gastric Mucinous Adenocarcinoma: A Case Report and Literature Review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
Original Research
Accepted on 29 Dec 2025
Glypican 3-Targeted Chimeric Antigen Receptor T Cells Secreting TROP2-Directed Bispecific T Cell Engagers Exhibit Potent Efficacy Against Lung Squamous Cell Carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Immunology